Citius Oncology Inc (NASDAQ:CTOR) does about 1.45M shares in volume on a normal day but saw 12501543 shares change hands in the recent trading day. The company now has a market cap of 88.01M USD. Its current market price is $1.23, marking an increase of 17.13% compared to the previous close of $1.05. The 52 week high reached by this stock is $49.00 whilst the lowest price level in 52 weeks is $0.55.
The consensus objective for the share price is $3.00, suggesting that the stock has a potential upside of 59.0% over the period.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on November 27, 2024 when Maxim Group initiated the stock to “Buy” and issued a price target of $3.
The current price level is 32.60%, 49.70%, and 10.21% away from its SMA20, SMA50, and SMA200 respectively, with the CTOR price moving below the 50-day SMA on current market day. Citius Oncology Inc (CTOR) stock is up 38.19% over the week and 45.56% over the past month. Its price is 6.96% year-to-date and -88.93% over the past year.
The company’s next earnings report forecasts estimating quarterly EPS at 0 and 0 for whole year.
To reach the target analysts have set, the stock logically needs to grow 59.0 percent from here.
Outstanding shares total 71.55M with insiders holding 95.07% of the shares and institutional holders owning 0.76% of the company’s common stock. The company has a return on investment of -52.88%. The forward price to earnings ratio is 24.60. The beta has a value of -0.06. Price to book ratio is 2.47.
